ODO. M. Dubin

O. M. Dubin

*This is an algorithmically generated author record based on publicly available information.

O. M. Dubin has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The effect of vitamin–amino acid contained feed additive on protein metabolism and liver and kidneys functioning in piglets

    by A. Yu. Melnyk, O. M. Dubin, V. S. Sakara, N. V. Vovkotrub, O. V. Chub, A. V. Rozumniuk, V. V. Hrytsai, O. V. Piddubnyak, M. M. Samorai, A. V. Kharchenko, et al.

    This study evaluated the effect of feed additive administration on the functional state of the liver and kidneys in piglets, based on indicators of protein, nitrogen, and lipid metabolism, as well as the activity of key enzymes aspartate aminotransferase (AST) and alanine aminotransferase (ALT). The experiment was carried out using piglets (35-days) from a farm in Kyiv region during 2023–2024. Animals were separated to control and experimental (n=6) groups. Blood biochemical parameters in both groups were within normal ranges and showed no significant differences before administration. After the first administration, the experimental group demonstrated an increase in total protein level. By the second blood sampling, the concentration had risen to 72.7 ± 0.99 g/L (P<0.1), and by the third to 76.2±1.21 g/L (P<0.05), with albumin levels reaching 41.55 ± 0.65% and 44.22 ± 0.17% (P<0.001), respectively, while the control group remained unaltered. These results indicate support of the liver’s albumin-synthesizing function under the influence of the preparation. Blood serum urea levels remained unchanged in both groups throughout the study, staying within the physiological norm, confirming the absence of negative effects on nitrogen metabolism. AST and ALT activities in the experimental group remained unaltered, whereas a gradual increase in AST was observed in the control group, indicating a better condition of hepatocytes in the treated animals. Creatinine concentrations were within normal limits in both groups, but statistically lower in the experimental group (P<0.05), further confirming the absence of nephrotoxic effects. Particular attention was paid to lipid metabolism indicators: in the experimental group, cholesterol levels significantly decreased to 1.70 ± 0.03 mmol/L (P<0.01) after two administrations, while remaining unchanged in the control group. The reduction of cholesterol within physiological limits is likely associated with activation of bile secretion and improvement of lipid metabolism processes rather than liver pathology, as supported by other biochemical parameters. Taking together, obtained results evidence that.